Literature DB >> 18687405

Conditional gp130 deficient mouse mutants.

Nicolas Fasnacht1, Werner Müller.   

Abstract

The common cytokine receptor chain, gp130, controls the activity of a group of cytokines, namely, IL-6, IL-11, IL-27, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin-1 (CT-1), cardiotrophin-like cytokine (CLC) and neuropoietin (NPN). This family of cytokines is involved in multiple different biological processes, including inflammation, acute phase response, immune responses and cell survival. To analyze the different components of the gp130 network, mouse mutants for the single cytokine were generated by conventional gene targeting. However, since the cytokines of the IL-6 family show redundancy, it does not reveal the complete picture. Therefore, the study of mice with a cell type specific inactivation of the gp130 receptor chain is an approach that will subsequently allow the dissection of the cellular cytokine network. Here, we summarize the experimental results of the conditional gp130 mutants published so far.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687405     DOI: 10.1016/j.semcdb.2008.07.001

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  23 in total

Review 1.  Adipogenesis.

Authors:  Kelesha Sarjeant; Jacqueline M Stephens
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

2.  Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.

Authors:  Carrie M Elks; Peng Zhao; Ryan W Grant; Hardy Hang; Jennifer L Bailey; David H Burk; Margaret A McNulty; Randall L Mynatt; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

3.  Molecular characterization and expression analysis of the putative interleukin 6 receptor (IL-6Rα and glycoprotein-130) in rainbow trout (Oncorhynchus mykiss): salmonid IL-6Rα possesses a polymorphic N-terminal Ig domain with variable numbers of two repeats.

Authors:  Maria M Costa; Tiehui Wang; Milena M Monte; Christopher J Secombes
Journal:  Immunogenetics       Date:  2011-10-29       Impact factor: 2.846

4.  A new synthetic varacin analogue, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), decreased hereditary catalepsy and increased the BDNF gene expression in the hippocampus in mice.

Authors:  Alexander V Kulikov; Maria A Tikhonova; Elizabeth A Kulikova; Konstantin P Volcho; Tatyana M Khomenko; Nariman F Salakhutdinov; Nina K Popova
Journal:  Psychopharmacology (Berl)       Date:  2011-11-30       Impact factor: 4.530

5.  Sortilin facilitates signaling of ciliary neurotrophic factor and related helical type 1 cytokines targeting the gp130/leukemia inhibitory factor receptor beta heterodimer.

Authors:  Jakob Vejby Larsen; Maria Hansen; Bjarne Møller; Peder Madsen; Jürgen Scheller; Morten Nielsen; Claus Munck Petersen
Journal:  Mol Cell Biol       Date:  2010-06-28       Impact factor: 4.272

Review 6.  The gp130 receptor cytokine family: regulators of adipocyte development and function.

Authors:  Ursula A White; Jacqueline M Stephens
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

7.  Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo.

Authors:  Ursula A White; William C Stewart; Jacqueline M Stephens
Journal:  Obesity (Silver Spring)       Date:  2010-12-16       Impact factor: 5.002

8.  Oncostatin M inhibits myoblast differentiation and regulates muscle regeneration.

Authors:  Fang Xiao; Haixia Wang; Xinrong Fu; Yanfeng Li; Kewei Ma; Luguo Sun; Xiang Gao; Zhenguo Wu
Journal:  Cell Res       Date:  2010-10-19       Impact factor: 25.617

9.  Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.

Authors:  David Sanchez-Infantes; Ursula A White; Carrie M Elks; Ron F Morrison; Jeffrey M Gimble; Robert V Considine; Anthony W Ferrante; Eric Ravussin; Jacqueline M Stephens
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

Review 10.  Impact of interleukin-6 in hematological malignancies.

Authors:  Renate Burger
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.